Income StatementBalance SheetCash FlowSegments
Eli Lilly logo

Eli Lilly Income Statement

Revenue, expenses, and profitability over time

Eli Lilly generated $72.2B in trailing twelve-month revenue, up 0.5% year-over-year. Net income was $25.3B with a 34.99% net margin. Diluted EPS is $28.15, which grew 1.3% year-over-year. Based on the Q1 2026 filing.

Total Revenue (TTM)$72.2BGross Profit (TTM)$59.8BNet Income (TTM)$25.3BEps Diluted (TTM)$28.15
Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$949.70B
P/E Ratio37.57
ROE107.65%

Operating Expenses

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquired IPR&D Expense$188.8M$1.6B$153.8M$655.7M$528.8M$584.0M
Acquired In-Process Research and Development$188.8M$1.6B$153.8M$655.7M$528.8M$584.0M
Acquired in-process research and development$188.8M$1.6B$153.8M$655.7M$528.8M$584.0M
Cost of sales, operating expenses, and other-net$8.5B$9.3B$8.8B$10.4B$11.0B$10.9B
Impairment and restructuring$344.4M$35.0M$0.0$364.9M$84.1M$279.0M
Cost Of Sales, Operating Expenses, And Other-net$8.5B$9.3B$8.8B$10.4B$11.0B$10.9B
Acquired in-process research and development expenses$188.8M$1.6B$153.8M$655.7M$528.8M$584.0M
Research and development$3.0B$2.7B$3.3B$3.5B$3.8B$3.5B
Selling, general and administrative$2.4B$2.5B$2.8B$2.7B$3.1B$2.9B

Earnings Per Share

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Basic earnings per share$4.90$3.07$6.30$6.22$7.40$8.27
Diluted earnings per share$4.88$3.06$6.29$6.21$7.39$8.26
Weighted-average shares, basic—898.7M897.9M896.9M—894.5M
Weighted-average shares, diluted—900.6M899.8M898.8M—895.9M

Operating Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Gross profit$11.1B$10.5B$13.1B$14.6B$15.9B$16.2B

Income Before Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income before income taxes$5.0B$3.5B$6.8B$7.2B$8.3B$8.9B

Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income tax expense$628.5M$697.0M$1.1B$1.6B$1.6B$1.5B

Net Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net income$4.4B$2.8B$5.7B$5.6B$6.6B$7.4B

Other Income & Expense

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other income (expense), net-$110.5M-$239.0M-$90.6M-$133.1M-$108.3M-$65.0M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Research and development expense$3.0B$2.7B$3.3B$3.5B$3.8B$3.5B

Cost of Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total cost of revenue$2.4B$2.2B$2.4B$3.0B$3.4B$3.6B

Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total revenue$13.5B$12.7B$15.6B$17.6B$19.3B$19.8B